Abstract:Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas-associated systems have recently emerged as a focal point for developing next-generation molecular diagnosis, particularly for nucleic acid detection. However, the detection of proteins is equally critical across diverse applications in biology, medicine, and the food industry, especially for diagnosing and prognosing diseases like cancer, Alzheimer and cardiovascular conditions. Despite recent efforts to adapt CRISPR/Cas systems for protein detection with immunoassays, these methods typically achieved sensitivity only in the femtomolar to picomolar range, underscoring the need for enhanced detection capabilities. To address this, we developed CRISPR-AMPED, an innovative CRISPR/Cas-based immunoassay enhanced by magnetic proximity extension and detection. This approach combines proximity extension assay (PEA) with magnetic beads that converts protein into DNA barcodes for quantification with effective washing steps to minimize non-specific binding and hybridization, therefore reducing background noise and increasing detection sensitivity. The resulting DNA barcodes are then detected through isothermal nucleic acid amplification testing (NAAT) using recombinase polymerase amplification (RPA) coupled with the CRISPR/Cas12a system, replacing the traditional PCR. This integration eliminates the need for thermocycling and bulky equipment, reduces amplification time, and provides simultaneous target and signal amplification, thereby significantly boosting detection sensitivity. CRISPR-AMPED achieves attomolar level sensitivity, surpassing ELISA by over three orders of magnitude and outperforming existing CRISPR/Cas-based detection systems. Additionally, our smartphone-based detection device demonstrates potential for point-of-care applications, and the digital format extends dynamic range and enhances quantitation precision. We believe CRISPR-AMPED represents a significant advancement in the field of protein detection.

Digitized Kinetic Analysis Enhances Genotyping Capacity of CRISPR-Based Biosensing

Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas System

Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6

Advances in Amplification-Free Detection of Nucleic Acid: CRISPR/Cas System As a Powerful Tool.

Design and Evaluation of a Robust CRISPR Kinetic Assay for Hot-Spot Genotyping

HRM-facilitated Rapid Identification and Genotyping of Mutations Induced by CRISPR/Cas9 Mutagenesis in Rice

CRISPR/cas systems redefine nucleic acid detection: Principles and methods

Universal and high-fidelity DNA single nucleotide polymorphism detection based on a CRISPR/Cas12a biochip

An Efficient CRISPR/Cas Cooperative Shearing Platform for Clinical Diagnostics Applications

Next-generation CRISPR/Cas-based ultrasensitive diagnostic tools: current progress and prospects

High-fidelity detection of DNA combining the CRISPR/Cas9 system and hairpin probe

Pathogen Detection Strategy Based on CRISPR

Nanozyme-catalysed CRISPR assay for preamplification-free detection of non-coding RNAs

Multiplexed CRISPR-Based Nucleic Acid Detection Using a Single Cas Protein

CRISPR-Cas assisted diagnostics: A broad application biosensing approach

Challenges and Opportunities for Clustered Regularly Interspaced Short Palindromic Repeats Based Molecular Biosensing

CRISPR/Cas Systems towards Next-Generation Biosensing

Microfluidics: the propellant of CRISPR-based nucleic acid detection

CRISPR-induced DNA reorganization for multiplexed nucleic acid detection

Detection of unamplified target genes via CRISPR–Cas9 immobilized on a graphene field-effect transistor

Enhanced CRISPR/Cas-Based Immunoassay through Magnetic Proximity Extension and Detection